Suppr超能文献

[环孢素A降低蛋白尿的机制:对肾小球阴离子位点的影响]

[Mechanism of reduction in proteinuria by cyclosporine A: effects on the glomerular anionic sites].

作者信息

Tanabe T

机构信息

Second Department of Internal Medicine, Hokkaido University School of Medicine, Japan.

出版信息

Hokkaido Igaku Zasshi. 1990 Jul;65(4):377-83.

PMID:2227790
Abstract

To consider the mechanism of reduction of proteinuria by cyclosporine A (CYA) in the patient with intractable nephrotic syndrome, the effect of CYA on proteinuria and anionic sites (AS) of the glomerular basement membrane (GBM) was studied in puromycin aminonucleoside (PA) nephrotic rats. In addition the rats exogenously given human recombinant interleukin-2 (hrIL-2) every day repeated the same proteinuria were used. The PA nephrotic rats were made by single injection of PA 150 mg/kg excrete of urinary protein as compared 10 mg/day of urinary protein in the controls. The increase of urinary protein in the PA rats was inhibited by CYA10-20 mg/kg administrated orally from the day of PA injection for 15 days. To evaluate AS, the kidney were treated with a polyethyleneimine (PEI) staining method and the deposits in the lamina rara externa (LRE) of the GBM were counted on the electron micrographs. On the 15th day, in the PA rats, AS decreased greatly but were normal in the CYA-treated rats. On one hand, rats injected of hr IL-2 2.5 X 10(5)U/rat intraperitoneally for 14 days showed slight proteinuria on the 14th day, and the proteinuria was also inhibited by oral administration of CYA 25 mg/kg. As reduced in the rats treated with hrIL-2 as well as PA. The findings indicate that the proteinuria in the PA nephrotic rats and rats treated with hrIL-2 might result from reduction of AS and that the improvement of proteinuria in these rats by CYA might be due to the recovery of AS in the GBM.

摘要

为探讨环孢素A(CYA)降低难治性肾病综合征患者蛋白尿的机制,我们在嘌呤霉素氨基核苷(PA)肾病大鼠中研究了CYA对蛋白尿及肾小球基底膜(GBM)阴离子位点(AS)的影响。此外,还使用了每天外源性给予重组人白细胞介素-2(hrIL-2)且出现相同蛋白尿的大鼠。PA肾病大鼠通过单次注射150mg/kg的PA制成,与对照组每天尿蛋白10mg相比,其尿蛋白排泄量增加。从注射PA当天起,口服给予10 - 20mg/kg的CYA,持续15天,可抑制PA大鼠尿蛋白的增加。为评估AS,采用聚乙烯亚胺(PEI)染色法处理肾脏,并在电子显微镜下对GBM外疏松层(LRE)中的沉积物进行计数。在第15天,PA大鼠的AS显著减少,但CYA治疗组大鼠的AS正常。另一方面,腹腔注射hrIL-2 2.5×10(5)U/大鼠,持续14天,在第14天出现轻微蛋白尿,口服25mg/kg的CYA也可抑制蛋白尿。与PA处理的大鼠一样,hrIL-2处理的大鼠也出现AS减少。这些结果表明,PA肾病大鼠和hrIL-2处理的大鼠蛋白尿可能是由于AS减少所致,而CYA改善这些大鼠的蛋白尿可能是由于GBM中AS的恢复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验